Merck KGaA Articles

OTHER USES FOR MERCK'S PROSCAR

18 May 1992

MERCK/ASTRA NEW FACILITY

18 May 1992

MERCK FROSST CANADA PROMOTIONS

18 May 1992

LIPID-LOWERING OF BENEFIT IN CANCER?

18 May 1992

NO BIG FOREIGN DRUG BUYS BY JAPANESE FIRMS

18 May 1992

JAPAN SUBSIDS DO WELL FOR MNCs

18 May 1992

BULLETIN REVIEWS ENZYME PRODUCTS

18 May 1992

US DRUG STOCKS AT A DISCOUNT

18 May 1992

EUROPEAN MARKET FOR SELF-MEDICATION

18 May 1992

MERCK AG 1991SALES RISE 12%

18 May 1992

STOCK MARKET COMMENTARY: NEW YORK

11 May 1992

IMPLICATIONS OF TECHNOLOGY

11 May 1992

WHO WILL SUCCEED MERCK & CO CHIEF?

11 May 1992

STUDY SUPPORTS ULCER/H PYLORI HYPOTHESIS

11 May 1992

US COMPETITIVENESS IN JAPAN DRUG MARKET By P Reed Maurer

11 May 1992

SWEDEN'S PHARMA MARKET IN 1991

11 May 1992

AUGMENTIN AS EFFECTIVE AS COMBO REGIMENS

4 May 1992

STOCK MARKET COMMENTARY: EUROPE

4 May 1992

STOCK MARKET COMMENTARY: NEW YORK

4 May 1992

US PUBLIC VACCINE PURCHASE THREAT

4 May 1992

REVENUES DECLINE, R&D UP AT SCIOS IN 1991

4 May 1992

SUCCESS IN A GLOBAL MARKETPLACE

4 May 1992

IMMUNOMEDICS PRESIDENT RESIGNS

27 April 1992

PROMOTIONS AT MERCK & CO

27 April 1992

MERCK & MERIEUX VACCINE DEAL

27 April 1992

GOOD SALES GROWTH FOR MAJOR US COS IN 1st QTR

27 April 1992

POST-ELECTION OUTLOOK FOR UK HEALTH SECTOR

20 April 1992

STRATEGIES TO ACHIEVE CRITICAL MASS

20 April 1992

STOCK MARKET COMMENTARY: NEW YORK

13 April 1992

US RESISTANCE TO DRUG PRICE RISES

13 April 1992

EURO DRUGMAKERS STOCK "UNDERVALUED"

6 April 1992

EURO DRUGMAKERS STOCK "UNDERVALUED"

6 April 1992

HYPOLIPIDEMICS INFO

23 March 1992

STRONGER WARNINGS ON ACE INHIBITORS

23 March 1992

US PRESCRIPTION PRICES UP 8.1%IN 1991

23 March 1992

GLAXO CHIEF ON PHARMA INDUSTRY, PUBLIC NEEDS

16 March 1992

MEDEVA'S ROAD TO SUCCESS

16 March 1992

MEVACOR WORKS IN FDB, SAYS STUDY

16 March 1992

INDUSTRY VIEWS US FDA CME GUIDE

16 March 1992

VOLUME GROWTH FOR US DRUGMAKERS

9 March 1992

VARIED FORTUNES FOR COLD REMEDIES

9 March 1992

NORTH AMERICA'S OTC COUGH COLD MARKET

9 March 1992

MENINGITIS VACCINE IN CANADA

9 March 1992

MERCK AFFIRMS SAFETY of MEVACOR

9 March 1992

BIOCHEM PHARMA'S JOHN GILLARD

9 March 1992

BELMAC CORP LOOKS TO USA

17 February 1992

STOCK MARKET COMMENTARY: NEW YORK

10 February 1992

MERCK'S PROSCAR NEARING US APPROVAL

10 February 1992

M&A IN JAPAN -- A PERSONAL PERSPECTIVE

3 February 1992

MS&D GREECE SALES RISE 19%

3 February 1992

B-M SQUIBB GIVES HEART DRUGS FREE TO POOR

3 February 1992

GOOD 1991 RESULTS FOR MERCK AND FOREST LABS

3 February 1992

ALZHEIMER'S DISEASE: US CONCERN

27 January 1992

FISONS UPDATES ON LEAD R&D PRODUCTS

27 January 1992

BANYU PINS HOPESON LIPOVAS

20 January 1992

US Rx DRUG PRICES ROSE 7.2% IN 1991

20 January 1992

FIRST LAUNCH OF LANSOPRAZOLE

20 January 1992

STOCK MARKET COMMENTARY: NEW YORK

20 January 1992

DECEMBER US APPROS REVIEWED

20 January 1992

US FDA BEATS 1990 DRUG APPROVALS IN 1991

13 January 1992

STOCK MARKET COMMENTARY: NEW YORK

13 January 1992

OPPORTUNE TIME FOR SB RELAFEN APPRO

13 January 1992

ANALGESICS IN THE USA -- AN OPEN DOOR FOR P&G?

6 January 1992

DRUG DISCOVERY IN JAPAN

6 January 1992

FEWER ACQUISITIONS AND MERGERS IN 1991

6 January 1992

US COUNTERING EXPENSIVE DRUGS

6 January 1992

SB JOINS MERCK TO MARKET ZOCOR

6 January 1992

MEDIMMUNE AND MERCK COMBINE IN AIDS RESEARCH

6 January 1992

UK TO EXPAND HEPATITIS IMMUNIZATION?

6 January 1992

ULCER DRUGS & ALCOHOL

6 January 1992

Merck & Co layoffs